{"title":"由自身免疫引起的低血糖","authors":"A. Ekladious","doi":"10.47363/jghr/2022(3)141","DOIUrl":null,"url":null,"abstract":"Hirata disease is an insulin autoimmune disease characterized by non-exogenous hyper insulinemic postprandial hypoglycemia due to elevated insulin autoimmune antibodies (IAS), with no exogenous insulin and no pathological abnormalities of pancreatic islets cells, the diagnosis is often missed due to the rarity of the disease, failure to diagnose Hirata disease in a timely manner often results in exposing the patients to unnecessary investigation and surgical procedures.","PeriodicalId":166372,"journal":{"name":"Journal of Gastroenterology & Hepatology Reports","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hypoglycaemia due to Autoimmunity\",\"authors\":\"A. Ekladious\",\"doi\":\"10.47363/jghr/2022(3)141\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hirata disease is an insulin autoimmune disease characterized by non-exogenous hyper insulinemic postprandial hypoglycemia due to elevated insulin autoimmune antibodies (IAS), with no exogenous insulin and no pathological abnormalities of pancreatic islets cells, the diagnosis is often missed due to the rarity of the disease, failure to diagnose Hirata disease in a timely manner often results in exposing the patients to unnecessary investigation and surgical procedures.\",\"PeriodicalId\":166372,\"journal\":{\"name\":\"Journal of Gastroenterology & Hepatology Reports\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Gastroenterology & Hepatology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jghr/2022(3)141\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastroenterology & Hepatology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jghr/2022(3)141","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hirata disease is an insulin autoimmune disease characterized by non-exogenous hyper insulinemic postprandial hypoglycemia due to elevated insulin autoimmune antibodies (IAS), with no exogenous insulin and no pathological abnormalities of pancreatic islets cells, the diagnosis is often missed due to the rarity of the disease, failure to diagnose Hirata disease in a timely manner often results in exposing the patients to unnecessary investigation and surgical procedures.